Abstract:Abstract Introduction N6‐methyladenosine (m6A) is the most prevalent modification that occurs in messenger RNA (mRNA), affecting mRNA splicing, translation, and stability. This modification is reversible, and its related biological functions are mediated by “writers,” “erasers,” and “readers.” The field of viral epitranscriptomics and the role of m6A modification in virus–host interaction have attracted much attention recently. When Epstein–Barr virus (EBV) infects a human B lymphocyte, it goes through three phases: the pre‐latent phase, latent phase, and lytic phase. Little is known about the viral and cellular m6A epitranscriptomes in EBV infection, especially in the pre‐latent phase during de novo infection. Methods Methylated RNA immunoprecipitation sequencing (MeRIP‐seq) and MeRIP‐RT‐qPCR were used to determine the m6A‐modified transcripts during de novo EBV infection. RIP assay was used to confirm the binding of EBNA2 and m6A readers. Quantitative reverse‐transcription polymerase chain reaction (RT‐qPCR) and Western blot analysis were performed to test the effect of m6A on the host and viral gene expression. Results Here, we provided mechanistic insights by examining the viral and cellular m6A epitranscriptomes during de novo EBV infection, which is in the pre‐latent phase. EBV EBNA2 and BHRF1 were highly m6A‐modified upon EBV infection. Knockdown of METTL3 (a “writer”) decreased EBNA2 expression levels. The emergent m6A modifications induced by EBV infection preferentially distributed in 3ʹ untranslated regions of cellular transcripts, while the lost m6A modifications induced by EBV infection preferentially distributed in coding sequence regions of mRNAs. EBV infection could influence the host cellular m6A epitranscriptome. Conclusions These results reveal the critical role of m6A modification in the process of de novo EBV infection.

Infection Phase-Dependent Dynamics of the Viral and Host N6-methyladenosine Epitranscriptome in the Lifecycle of an Oncogenic Virus in Vivo

N6-methyladenosine and viral infection

Comprehensive profiling analysis of the N6-methyladenosine-modified circular RNA transcriptome in cultured cells infected with Marek’s disease virus

Expression Profiles Of Micrornas Encoded By The Oncogenic Marek'S Disease Virus Reveal Two Distinct Expression Patterns In Vivo During Different Phases Of Disease

Identification of an N6-methyladenosine-mediated positive feedback loop that promotes Epstein–Barr virus infection

Transcriptome-wide N6-methyladenosine modification and microRNA jointly regulate the infection of avian leukosis virus subgroup J in vitro

Pathogenic Roles of M6a Modification in Viral Infection and Virus-Driven Carcinogenesis.

Transcriptome-wide N6-methyladenosine Modification Profiling of Mrnas During Infection of Newcastle Disease Virus in Chicken Macrophages

RNA M6a Methylation Regulates Virus–host Interaction and EBNA2 Expression During Epstein–Barr Virus Infection

Pathogenic Roles of m6A Modification in Viral Infection and Virus-driven Carcinogenesis

Viral and Cellular N 6 -Methyladenosine and N 6 ,2′- O -Dimethyladenosine Epitranscriptomes in the KSHV Life Cycle

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Decoding epitranscriptomic regulation of viral infection: mapping of RNA N6-methyladenosine by advanced sequencing technologies

Regulation of Virus Replication and T Cell Homeostasis by N6-Methyladenosine

Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells

Regulation of Antiviral Immune Response by N6-Methyladenosine of mRNA

N6-methyladenosine modification—a key player in viral infection

Critical Roles of Non-Coding RNAs in Lifecycle and Biology of Marek’s Disease Herpesvirus

A Novel Method for Genome-Wide Profiling of Dynamic Host-Pathogen Interactions Using 3′ End Enriched RNA-seq

Regulation of Virus Replication and T Cell Homeostasis by N 6 -Methyladenosine

Gene expression analysis of host spleen responses to Marek's disease virus infection at late tumor transformation phase.